NUCLEOTIDES MODULATE THE LOW AFFINITY BINDING-SITES FOR [H-3] GLIBENCLAMIDE IN THE RAT-BRAIN

被引:0
|
作者
ZINI, S [1 ]
ZINI, R [1 ]
BENARI, Y [1 ]
机构
[1] FAC MED PARIS 12,DEPT PHARMACOL,F-94010 CRETEIL,FRANCE
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Receptors for hypoglycemic sulfonylureas. such as glibenclamide, are commonly linked to the activity of ATP-sensitive K+ channels (K-ATP). High and low affinity binding sites for glibenclamide were described previously in numerous tissues. High affinity binding sites have been thought to be responsible of the modulation of K-ATP, but new evidences suggest that low affinity ones could also regulate these channels. In order to clarify the properties of the two binding sites, with respect to their interaction with K-ATP, we characterized biochemically and pharmacologically [H-3]glibenclamide binding in the rat brain cortex. Competitive inhibition plots with [H-3]glibenclamide performed on membranes of adult and neonatal rat brain cortex exhibited a biphasic pattern with similar binding parameters, indicating the presence of two similar binding sites in adult as well as in neonatal animals. Membranes of adult rat cortex treated with thiol groups modifying agents, N-ethylmaleimide or 1,4-dithiothreitol, increased the inhibition constant of glibenclamide for the low affinity binding sites (K(i)L) by about 4-fold. The divalent cations Mg++ and Ca++ also increased K(i)L by 3- to 6-fold and enhanced the low affinity binding capacity (B(max)L) by 55 and 103%, respectively, both cations increasing B(max)L by 144%. Among the numerous nucleotides studied, adenine and guanidine triphosphate nucleotides were the most potent to affect the low affinity binding sites. ATP, ADP, GTP and respective nonhydrolysable nucleotides increased K(i)L by 7- to 12-fold and decreased B(max)L by 10 to 30%. The effects of nucleotides were not Mg++ dependent. Our extensive pharmacological study showed that only few compounds were able to inhibit the binding of [H-3]glibenclamide to its high or low affinity binding sites. Conversely, glibenclamide failed to inhibit a large number of selective radioligands for different receptors. It is concluded that the low affinity binding sites for glibenclamide are most sensitive to divalent cations and nucleotides than the high affinity ones and could interfere with ATP-sensitive or other nonrelated potassium channels.
引用
收藏
页码:701 / 708
页数:8
相关论文
共 50 条
  • [41] [H-3] RYANODINE BINDING-SITES IN RAT-BRAIN DEMONSTRATED BY MEMBRANE-BINDING AND AUTORADIOGRAPHY
    PADUA, RA
    WAN, WH
    NAGY, JI
    GEIGER, JD
    BRAIN RESEARCH, 1991, 542 (01) : 135 - 140
  • [42] CHARACTERIZATION OF THE BINDING-SITES FOR [H-3] GLIBENCLAMIDE IN RAT-LIVER MEMBRANES
    INOUE, Y
    EMOTO, M
    INOUE, H
    KAKU, K
    KANEKO, T
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 284 (1-2) : 77 - 82
  • [43] QUANTITATIVE AUTORADIOGRAPHY OF [H-3] NORHARMAN ([H-3]BETA-CARBOLINE) BINDING-SITES IN THE RAT-BRAIN
    PAWLIK, M
    KAULEN, P
    BAUMGARTEN, HG
    ROMMELSPACHER, H
    JOURNAL OF CHEMICAL NEUROANATOMY, 1990, 3 (01) : 19 - 24
  • [44] LIGHT MICROSCOPIC AUTORADIOGRAPHIC LOCALIZATION OF [H-3] GLYCINE AND [H-3] STRYCHNINE BINDING-SITES IN RAT-BRAIN
    BRISTOW, DR
    BOWERY, NG
    WOODRUFF, GN
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 126 (03) : 303 - 307
  • [45] MULTIPLICITY OF [H-3] 1,3-DI-O-TOLYLGUANIDINE BINDING-SITES WITH LOW-AFFINITY FOR HALOPERIDOL IN RAT-BRAIN
    ENOMOTO, R
    OGITA, K
    YONEDA, Y
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1993, 16 (10) : 989 - 996
  • [46] STEREOSPECIFIC BINDING-SITES FOR [H-3] NICOTINAMIDE ADENINE-DINUCLEOTIDE IN THE RAT-BRAIN
    SNELL, PH
    SNELL, CR
    RICHARDS, CD
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 116 (1-2) : 121 - 127
  • [47] [H-3]TRYPTAMINE BINDING-SITES ARE NOT IDENTICAL TO MONOAMINE-OXIDASE IN RAT-BRAIN
    PERRY, DC
    GRIMM, LJ
    KETTLER, KG
    KELLAR, KJ
    JOURNAL OF NEUROCHEMISTRY, 1988, 51 (05) : 1535 - 1540
  • [48] AUTORADIOGRAPHIC DISTRIBUTION OF NONDOPAMINERGIC BINDING-SITES LABELED [H-3] HALOPERIDOL IN RAT-BRAIN
    CONTRERAS, PC
    QUIRION, R
    GEHLERT, DR
    CONTRERAS, ML
    ODONOHUE, TL
    NEUROSCIENCE LETTERS, 1987, 75 (02) : 133 - 140
  • [49] DIFFERENT CHARACTERISTICS OF H-3 CALCIUM-ANTAGONIST BINDING-SITES IN THE RAT-BRAIN
    MATSUBAYASHI, H
    KITO, S
    MIYOSHI, R
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P84 - P84
  • [50] QUANTITATIVE LIGHT MICROSCOPIC LOCALIZATION OF [H-3] NALTRINDOLE BINDING-SITES IN THE RAT-BRAIN
    DROWER, EJ
    DORN, CR
    MARKOS, CS
    UNNERSTALL, JR
    RAFFERTY, MF
    CONTRERAS, PC
    BRAIN RESEARCH, 1993, 602 (01) : 138 - 142